Buda-Nowak, A., Kucharz, J., Dumnicka, P., Kuzniewski, M., Herman, R. M., Zygulska, A. L., & Kusnierz-Cabala, B. (2017). Sunitinib-induced hypothyroidism predicts progression-free survival in metastatic renal cell carcinoma patients. Med Oncol.
Παραπομπή Chicago StyleBuda-Nowak, Anna, Jakub Kucharz, Paulina Dumnicka, Marek Kuzniewski, Roman Maria Herman, Aneta L. Zygulska, και Beata Kusnierz-Cabala. "Sunitinib-induced Hypothyroidism Predicts Progression-free Survival in Metastatic Renal Cell Carcinoma Patients." Med Oncol 2017.
Παραπομπή MLABuda-Nowak, Anna, et al. "Sunitinib-induced Hypothyroidism Predicts Progression-free Survival in Metastatic Renal Cell Carcinoma Patients." Med Oncol 2017.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.